Treace Medical Concepts, Inc. (TMCI) Profit Margin
Treace Medical Concepts, Inc. (TMCI) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2021-12-31 | -21.77% |
| 2022-12-31 | -30.19% |
| 2023-12-31 | -26.47% |
| 2024-12-31 | -26.63% |
| 2025-12-31 | -27.74% |
How TMCI compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| EOLS | Evolus Inc. | -17.38% |
| FLGT | Fulgent Genetics Inc. | -18.75% |
| STIM | Neuronetics Inc. | -26.15% |
| AXSM | Axsome Therapeutics Inc. | -28.69% |
| PRGO | Perrigo Company plc | -33.51% |
These are five companies in the same sector as TMCI with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Treace Medical Concepts, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("TMCI", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | TMCI | $4.57 | +2.70% | 0.26M |
| 3 | ||||
| 4 | ||||
| 5 |